Digestive & Intestinal Remedies (Pharmacies) - Mozambique

  • Mozambique
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$1.79m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 9.90%, resulting in a market volume of US$2.87m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.05 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Mozambique is experiencing significant growth due to increasing customer preferences for over-the-counter remedies, along with several local special circumstances and underlying macroeconomic factors. Customer preferences in Mozambique are shifting towards self-medication and seeking immediate relief for digestive and intestinal issues. This trend is driven by the convenience and accessibility of over-the-counter remedies available at pharmacies. Customers prefer to address minor digestive problems such as indigestion, heartburn, and diarrhea on their own, without the need for a doctor's prescription. This preference for self-medication is also influenced by the busy lifestyles of Mozambicans, who are looking for quick and effective solutions to their health issues. The market is also witnessing an increase in the demand for natural and herbal remedies, as customers become more conscious of the potential side effects of conventional medicines. Natural remedies are perceived as safer and gentler on the body, leading to a growing preference for products that contain natural ingredients. This trend aligns with the global shift towards natural and organic products, reflecting the increasing awareness of the importance of holistic health and well-being. In addition to customer preferences, several local special circumstances contribute to the development of the Digestive & Intestinal Remedies market in Mozambique. The country has a high prevalence of gastrointestinal diseases, including parasitic infections and foodborne illnesses. This creates a significant demand for remedies that can alleviate symptoms and provide relief. Furthermore, Mozambique's healthcare system faces challenges in terms of accessibility and affordability, leading to a reliance on self-medication and over-the-counter remedies. Underlying macroeconomic factors also play a role in the growth of the market. Mozambique has been experiencing steady economic growth in recent years, leading to an increase in disposable income and purchasing power. This allows consumers to afford healthcare products and invest in their well-being. Additionally, the country's growing middle class is becoming more health-conscious and willing to spend on preventive measures and remedies. Overall, the Digestive & Intestinal Remedies (Pharmacies) market in Mozambique is developing due to customer preferences for self-medication and natural remedies, local special circumstances related to the prevalence of gastrointestinal diseases, and underlying macroeconomic factors such as economic growth and increased disposable income. As the market continues to evolve, it is expected that there will be a greater emphasis on preventive measures and a wider range of product options to cater to diverse customer needs and preferences.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)